New Drugs for Psychosis & Schizophrenia
The Lancet May 5 2018 FDA Pimavanserin review
Help for often-hidden illnesses
The Lancet May 5 2018 FDA Pimavanserin review
With the deadline for legalization of nonmedical marijuana approaching, scientists studying the health impacts of cannabis are calling on the federal government to implement a comprehensive research program. “Considerably more …
Spending by Canadian governments on patented drugs costing more than $10 000 per patient annually increased 60% in 2016 . Spending on brand-name pharmaceuticals as a whole rose 18%.
BC Prisons Saving Lives by Giving Drugs to Prisoners
CMAJ April 18 2017 Canada Wins Legal Battle to Set Patent Rules
Lancet Jan 20 2017 Calls for Medically Safe Heroin Mount in Canada
The Lancet June 18 2016 Canada’s Indigenous Suicide Crisis